Schedule 13G ownership disclosure

Bicara Therapeutics Inc

COMMON STOCK · CUSIP: 055477103

Event date: 2025-12-31

Filing-level shares
3,236,595
Percent of class
5.9%
  • T. Rowe Price Investment Management, Inc.

    Shares: 3,236,595 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-26-000288
Form type
SCHEDULE 13G
Filer
Bicara Therapeutics Inc.
CIK
CIK 2023658
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub